Jonathan M. Meyer

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline

Henry A. Nasrallah, Jonathan M. Meyer, Donald Goff et al. · Schizophrenia Research · 2006 · 553 citations

Hypertension, Psychiatry, Antihypertensive Therapy +5

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

Donald Goff, Lisa Sullivan, Joseph P. McEvoy et al. · Schizophrenia Research · 2005 · 526 citations

Risk Prediction, Psychiatry, Cardiovascular Disease +8

A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients

Jonathan M. Meyer · The Journal of Clinical Psychiatry · 2002 · 267 citations

The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome

Jonathan M. Meyer, Henry A. Nasrallah, Joseph P. McEvoy et al. · Schizophrenia Research · 2005 · 210 citations

Intervention Effectiveness, Metabolic Syndrome, Psychiatry +9

Phenomenology of and Risk Factors for New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Atypical Antipsychotics: An Analysis of 45 Published Cases

Hua Jin, Jonathan M. Meyer, Dilip V. Jeste · Annals of Clinical Psychiatry · 2002 · 201 citations

Psychiatry, Atypical Antipsychotics, Diabetes +5